Emicrania emiplegica familiare

[1]  B. P. Van de Warrenburg,et al.  The complexities of CACNA1A in clinical neurogenetics , 2021, Journal of Neurology.

[2]  F. Viallet,et al.  Hemiplegic Migraine Associated With PRRT2 Mutations: A Clinical and Genetic Study. , 2021, Neurology.

[3]  P. Gavazzo,et al.  Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model , 2021, The Journal of clinical investigation.

[4]  Shanshan Kong,et al.  Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms , 2021, The Journal of Headache and Pain.

[5]  A. Ducros.  Genetics of migraine. , 2021, Revue neurologique.

[6]  I. Scheffer,et al.  ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. , 2021, Brain : a journal of neurology.

[7]  Misha Patel,et al.  Serial magnetic resonance imaging findings during severe attacks of familial hemiplegic migraine type 2: a case report , 2021, BMC Neurology.

[8]  B. Baykan,et al.  Epilepsy in patients with familial hemiplegic migraine , 2021, Seizure.

[9]  S. Boesch,et al.  From Genotype to Phenotype: Expanding the Clinical Spectrum of CACNA1A Variants in the Era of Next Generation Sequencing , 2021, Frontiers in Neurology.

[10]  S. Sisodiya,et al.  RHOBTB2 mutations expand the phenotypic spectrum of alternating hemiplegia of childhood. , 2021, Neurology.

[11]  Jonathan R Bumstead,et al.  Astrocyte deletion of α2-Na/K ATPase triggers episodic motor paralysis in mice via a metabolic pathway , 2020, Nature Communications.

[12]  Robert A. Smith,et al.  Comprehensive Exonic Sequencing of Hemiplegic Migraine-Related Genes in a Cohort of Suspected Probands Identifies Known and Potential Pathogenic Variants , 2020, Cells.

[13]  R. Abou Jamra,et al.  Hemiplegic Migraine in Glut1 Deficiency Syndrome and Paroxysmal Dyskinesia at Ketogenic Diet Induction: Case Report and Literature Review , 2020, Movement disorders clinical practice.

[14]  C. Napoli,et al.  Diagnostic and therapeutic aspects of hemiplegic migraine , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  I. Scheffer,et al.  SCN1A‐related phenotypes: Epilepsy and beyond , 2019, Epilepsia.

[16]  Donald D. McGeary,et al.  A Retrospective, Epidemiological Review of Hemiplegic Migraines in a Military Population. , 2019, Military medicine.

[17]  A. Vasiljevic,et al.  A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants. , 2019, Brain : a journal of neurology.

[18]  Massimiliano Valeriani,et al.  First Attack and Clinical Presentation of Hemiplegic Migraine in Pediatric Age: A Multicenter Retrospective Study and Literature Review , 2019, Front. Neurol..

[19]  J. Lacaille,et al.  Both gain‐of‐function and loss‐of‐function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox‐Gastaut syndrome , 2019, Epilepsia.

[20]  H. Sutherland,et al.  Advances in genetics of migraine , 2019, The Journal of Headache and Pain.

[21]  P. Jouk,et al.  Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. , 2019, European journal of medical genetics.

[22]  B. Echenne,et al.  Cognitive impairment in children with CACNA1A mutations , 2019, Developmental medicine and child neurology.

[23]  A. Ferbert,et al.  Multimodal imaging findings during severe attacks of familial hemiplegic migraine type 2 , 2018, Journal of the Neurological Sciences.

[24]  K. Mokhtari,et al.  Neuronal injuries evidenced by transient cortical magnetic resonance enhancement in hemiplegic migraine: A case report , 2018, Cephalalgia : an international journal of headache.

[25]  Carrie E. Robertson,et al.  The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients , 2018, Headache.

[26]  F. Benfenati,et al.  PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity , 2018, Brain : a journal of neurology.

[27]  A. Palotie,et al.  The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families , 2018, Cephalalgia : an international journal of headache.

[28]  Stephany C. Koelewijn,et al.  Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation , 2018, Neurology.

[29]  P. Calabresi,et al.  Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications , 2018, Cephalalgia : an international journal of headache.

[30]  M. Ferrari,et al.  Combined early treatment in hemiplegic attacks related to CACNA1A encephalopathy with brain oedema: Blocking the cascade? , 2017, Cephalalgia : an international journal of headache.

[31]  M. Ferrari,et al.  Brain atrophy following hemiplegic migraine attacks , 2017, Cephalalgia : an international journal of headache.

[32]  N. Pelzer,et al.  Recurrent coma and fever in familial hemiplegic migraine type 2. A prospective 15-year follow-up of a large family with a novel ATP1A2 mutation , 2017, Cephalalgia : an international journal of headache.

[33]  L. Caniatti,et al.  De novo exonic duplication of ATP1A2 in Italian patient with hemiplegic migraine: a case report , 2017, The Journal of Headache and Pain.

[34]  R. Corominas,et al.  Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia , 2017, Scientific Reports.

[35]  S. Beyenburg,et al.  Hemiplegic Migraine Presenting with Prolonged Somnolence: A Case Report , 2016, Case Reports in Neurology.

[36]  S. Fukuda,et al.  Time course of downbeat positioning nystagmus in familial hemiplegic migraine type 1 treated with acetazolamide , 2016, Journal of the Neurological Sciences.

[37]  M. Santello,et al.  Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2 , 2016, EMBO molecular medicine.

[38]  T. Friedrich,et al.  ATP1A2 Mutations in Migraine: Seeing through the Facets of an Ion Pump onto the Neurobiology of Disease , 2016, Front. Physiol..

[39]  M. Lauritzen,et al.  Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model , 2016, Scientific Reports.

[40]  L. Bendtsen,et al.  Familial Hemiplegic Migraine and Recurrent Episodes of Psychosis: A Case Report , 2015, Headache.

[41]  L. Gagnon,et al.  CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms , 2015, European Journal of Human Genetics.

[42]  C. Lines,et al.  Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention , 2014, Neurology.

[43]  P. Maeder,et al.  Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A , 2014, Journal of the Neurological Sciences.

[44]  F. Bolster,et al.  Hemiplegic Migraine: Neuroimaging Findings During a Hemiplegic Migraine Attack , 2014, Headache.

[45]  H. Lerche,et al.  Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. , 2013, Pediatric neurology.

[46]  C. Hong,et al.  Prolonged symptoms in sporadic hemiplegic migraine: aura or migrainous infarction? , 2012, Acta neurologica Taiwanica.

[47]  J. Barros,et al.  Psychotic aura symptoms in familial hemiplegic migraine type 2 (ATP1A2) , 2012, The Journal of Headache and Pain.

[48]  J. Barros,et al.  Sporadic hemiplegic migraine with normal imaging as the initial manifestation of CADASIL , 2012, Cephalalgia : an international journal of headache.

[49]  J. Olesen,et al.  Trigger factors for familial hemiplegic migraine , 2011, Cephalalgia : an international journal of headache.

[50]  T. Pizzorusso,et al.  Increased Susceptibility to Cortical Spreading Depression in the Mouse Model of Familial Hemiplegic Migraine Type 2 , 2011, PLoS genetics.

[51]  M. Russell,et al.  Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management , 2011, The Lancet Neurology.

[52]  L. Santoro,et al.  A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation , 2011, Cephalalgia : an international journal of headache.

[53]  J. Olesen,et al.  Characterization of consistent triggers of migraine with aura , 2011, Cephalalgia : an international journal of headache.

[54]  C. Depienne,et al.  De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine , 2010, Neurology.

[55]  K. Mikoshiba,et al.  Defective membrane expression of the Na+-HCO3− cotransporter NBCe1 is associated with familial migraine , 2010, Proceedings of the National Academy of Sciences.

[56]  C. Hommet,et al.  The FHM1 Mutation S218L: A Severe Clinical Phenotype? A Case Report and Review of the Literature , 2009, Cephalalgia : an international journal of headache.

[57]  M. Ferrari,et al.  Molecular genetics of migraine , 2009, Human Genetics.

[58]  C. Depienne,et al.  Elicited repetitive daily blindness , 2009, Neurology.

[59]  Gogi Kumar,et al.  Familial Hemiplegic Migraine With Prolonged Aura and Multimodality Imaging: A Case Report , 2009, Headache.

[60]  M. Moskowitz,et al.  Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. , 2008, The Journal of clinical investigation.

[61]  E. Donner,et al.  Stepwise developmental regression associated with novel CACNA1A mutation. , 2008, Pediatric neurology.

[62]  P. Striano,et al.  Topiramate-associated worsening symptoms in a patient with familial hemiplegic migraine , 2008, Journal of the Neurological Sciences.

[63]  J. Olesen,et al.  Calcitonin gene–related peptide does not cause the familial hemiplegic migraine phenotype , 2008, Neurology.

[64]  Massimo Mantegazza,et al.  Self-Limited Hyperexcitability: Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+ Channel , 2008, The Journal of Neuroscience.

[65]  J. Olesen,et al.  Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide , 2008, Cephalalgia : an international journal of headache.

[66]  J. Olesen,et al.  Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine , 2008, Cephalalgia : an international journal of headache.

[67]  M. Dichgans,et al.  Expansion of the Phenotypic Spectrum of the CACNA1A T666M Mutation: A Family with Familial Hemiplegic Migraine Type 1, Cerebellar Atrophy and Mental Retardation , 2008, Cephalalgia : an international journal of headache.

[68]  R. Baloh,et al.  Adult-Onset Hemiplegic Migraine with Cortical Enhancement and Oedema , 2007, Cephalalgia : an international journal of headache.

[69]  A. Palotie,et al.  Treatment of hemiplegic migraine with triptans , 2007, European journal of neurology.

[70]  D. Black.  Sporadic and familial hemiplegic migraine: diagnosis and treatment. , 2006, Seminars in neurology.

[71]  C. Caltagirone,et al.  A Novel ATP1A2 Mutation in a Family with FHM Type II , 2006, Cephalalgia : an international journal of headache.

[72]  M. Ferrari,et al.  Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation , 2006, Annals of neurology.

[73]  H. Diener,et al.  Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[74]  Y. Kuroiwa,et al.  Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[75]  F. Lehmann-Horn,et al.  A G301R Na+/K+-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs , 2005, Neurogenetics.

[76]  E. Bamberg,et al.  Na,K-ATPase mutations in familial hemiplegic migraine lead to functional inactivation. , 2005, Biochimica et biophysica acta.

[77]  M Wilke,et al.  1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1 , 2005, Neurology.

[78]  A. Safran,et al.  Elicited repetitive daily blindness , 2004, Neurology.

[79]  M. Dichgans,et al.  Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants , 2004, Neurology.

[80]  Simon Kaja,et al.  A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression , 2004, Neuron.

[81]  M. Moskowitz,et al.  Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes , 2004, Annals of neurology.

[82]  J. Hottenga,et al.  Novel mutations in the Na+, K+‐ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions , 2003, Annals of neurology.

[83]  T. Rozen.  Aborting a Prolonged Migrainous Aura With Intravenous Prochlorperazine and Magnesium Sulfate , 2003, Headache.

[84]  J. Olesen,et al.  Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives , 2003, European journal of neurology.

[85]  M. Ferrari,et al.  Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. , 2003, Archives of neurology.

[86]  J. Olesen,et al.  Evidence for a separate type of migraine with aura , 2003, Neurology.

[87]  A. Ballabio,et al.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2 , 2003, Nature Genetics.

[88]  J. Tippin,et al.  Prolonged Cortical Electrical Depression and Diffuse Vasospasm Without Ischemia in a Case of Severe Hemiplegic Migraine During Pregnancy , 2003, Headache.

[89]  C. Fletcher,et al.  Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Olesen,et al.  An Epidemiological Survey of Hemiplegic Migraine , 2002, Cephalalgia : an international journal of headache.

[91]  J. Olesen,et al.  A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. , 2002, Brain : a journal of neurology.

[92]  S. Horowitz,et al.  Familial hemiplegic migraine and its abortive therapy with intravenous verapamil , 2001, Neurology.

[93]  E. Vicaut,et al.  The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. , 2001, The New England journal of medicine.

[94]  S. Love,et al.  Delayed cerebral edema and fatal coma after minor head trauma: Role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine , 2001, Annals of neurology.

[95]  R. Ophoff,et al.  Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura , 2001, Neurology.

[96]  J. Castaldo,et al.  Hemiplegic Migraine During Pregnancy: Unusual Magnetic Resonance Appearance With SPECT Scan Correlation , 2001, Headache.

[97]  H. Chabriat,et al.  CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy , 2000, Neurology.

[98]  T. Rozen.  Treatment of a prolonged migrainous aura with intravenous furosemide , 2000, Neurology.

[99]  H. Adams,et al.  Hemiplegic migraine induced by exertion. , 2000, Archives of neurology.

[100]  H. Diener,et al.  Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine , 2000, Neurology.

[101]  F. Rivier,et al.  Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. , 1999, Neuropediatrics.

[102]  N. Battistini,et al.  A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia , 1999, Neurology.

[103]  R. Ophoff,et al.  Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine , 1998, Neurology.

[104]  L. Sandkuijl,et al.  Partial Cosegregation of Familial Hemiplegic Migraine and a Benign Familial Infantile Epileptic Syndrome , 1997, Epilepsia.

[105]  Dennis E Bulman,et al.  Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 , 1996, Cell.

[106]  S. Gilman,et al.  Acetazolamide responsiveness in familial hemiplegic migraine , 1996, Annals of neurology.

[107]  S. Peroutka,et al.  Familial hemiplegic migraine, nystagmus, and cerebellar atrophy , 1996, Annals of neurology.

[108]  M. Ferrari,et al.  Is Familial Hemiplegic Migraine a Hereditary form of Basilar Migraine? , 1995, Cephalalgia : an international journal of headache.

[109]  V. Rajput,et al.  Adult Onset Familial Hemiplegic Migraine , 1995, Headache.

[110]  T. Olsen,et al.  Timing and topography of cerebral blood flow, aura, and headache during migraine attacks , 1990, Annals of neurology.

[111]  Sadao Takase,et al.  A Case of Hemiplegic Migraine Treated with Flunarizine , 1987, Headache.

[112]  R. Fitzsimons,et al.  Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. , 1985, Brain : a journal of neurology.

[113]  O. Albano,et al.  Non-Familial Hemiplegic Migraine Responsive to Naloxone , 1983, Cephalalgia : an international journal of headache.

[114]  K. S. Ferguson,et al.  Life-threatening migraine. , 1982, Archives of neurology.

[115]  J. Green,et al.  Familial hemiplegic migraine, retinal degeneration, deafness, and nystagmus. , 1970, Archives of neurology.

[116]  F. Tamanini,et al.  Familial hemiplegic migraine. , 1955, The Lancet.

[117]  J. Clarke.  On Recurrent Motor Paralysis in Migraine, with Report of a Family in which Recurrent Hemiplegia Accompanied the Attacks , 1910, British medical journal.

[118]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.

[119]  A. Ducros.  [Familial and sporadic hemiplegic migraine]. , 2008, Revue neurologique.